Found: 35
Select item for more details and to access through your institution.
Authors' reply to the Letter to the Editor: Tissue factor and its procoagulant activity on cancer‐associated thromboembolism in pancreatic cancer.
- Published in:
- Cancer Science, 2022, v. 113, n. 5, p. 1888, doi. 10.1111/cas.15324
- By:
- Publication type:
- Article
Transcriptional suppression of Dicer by HOXB‐AS3/EZH2 complex dictates sorafenib resistance and cancer stemness.
- Published in:
- Cancer Science, 2022, v. 113, n. 5, p. 1601, doi. 10.1111/cas.15319
- By:
- Publication type:
- Article
How are new drugs disseminated in Japan? Analysis using the National Database of Health Insurance Claims of Japan.
- Published in:
- Cancer Science, 2022, v. 113, n. 5, p. 1771, doi. 10.1111/cas.15322
- By:
- Publication type:
- Article
Intraperitoneal administration of nanoparticles containing tocopheryl succinate prevents peritoneal dissemination.
- Published in:
- Cancer Science, 2022, v. 113, n. 5, p. 1779, doi. 10.1111/cas.15321
- By:
- Publication type:
- Article
High PD‐L1 level of advanced hepatic lymphoepithelioma‐like carcinoma response favorably to lenvatinib plus toripalimab.
- Published in:
- Cancer Science, 2022, v. 113, n. 5, p. 1880, doi. 10.1111/cas.15339
- By:
- Publication type:
- Article
CORRECTION.
- Published in:
- Cancer Science, 2022, v. 113, n. 5, p. 1891, doi. 10.1111/cas.15343
- Publication type:
- Article
Exosomal miR‐106a‐5p accelerates the progression of nasopharyngeal carcinoma through FBXW7‐mediated TRIM24 degradation.
- Published in:
- Cancer Science, 2022, v. 113, n. 5, p. 1652, doi. 10.1111/cas.15337
- By:
- Publication type:
- Article
Histone H1.2 promotes hepatocarcinogenesis by regulating signal transducer and activator of transcription 3 signaling.
- Published in:
- Cancer Science, 2022, v. 113, n. 5, p. 1679, doi. 10.1111/cas.15336
- By:
- Publication type:
- Article
Evaluation of a novel medical device for pegfilgrastim administration.
- Published in:
- Cancer Science, 2022, v. 113, n. 5, p. 1763, doi. 10.1111/cas.15335
- By:
- Publication type:
- Article
Tumor endothelial cell‐induced CD8<sup>+</sup> T‐cell exhaustion via GPNMB in hepatocellular carcinoma.
- Published in:
- Cancer Science, 2022, v. 113, n. 5, p. 1625, doi. 10.1111/cas.15331
- By:
- Publication type:
- Article
Perioperative circulating tumor DNA enables the identification of patients with poor prognosis in upper tract urothelial carcinoma.
- Published in:
- Cancer Science, 2022, v. 113, n. 5, p. 1830, doi. 10.1111/cas.15334
- By:
- Publication type:
- Article
Bone morphogenetic protein receptor 1α promotes osteolytic lesion of oral squamous cell carcinoma by SHH‐dependent osteoclastogenesis.
- Published in:
- Cancer Science, 2022, v. 113, n. 5, p. 1639, doi. 10.1111/cas.15330
- By:
- Publication type:
- Article
Feasibility study on collecting patient‐reported outcomes from breast cancer patients using the LINE‐ePRO system.
- Published in:
- Cancer Science, 2022, v. 113, n. 5, p. 1722, doi. 10.1111/cas.15329
- By:
- Publication type:
- Article
Clinical impact of genetic alterations of CTNNB1 in patients with grade 3 endometrial endometrioid carcinoma.
- Published in:
- Cancer Science, 2022, v. 113, n. 5, p. 1712, doi. 10.1111/cas.15328
- By:
- Publication type:
- Article
Deubiquitinase ubiquitin‐specific peptidase 10 maintains cysteine rich angiogenic inducer 61 expression via Yes1 associated transcriptional regulator to augment immune escape and metastasis of pancreatic adenocarcinoma.
- Published in:
- Cancer Science, 2022, v. 113, n. 5, p. 1868, doi. 10.1111/cas.15326
- By:
- Publication type:
- Article
The metabolomic landscape plays a critical role in glioma oncogenesis.
- Published in:
- Cancer Science, 2022, v. 113, n. 5, p. 1555, doi. 10.1111/cas.15325
- By:
- Publication type:
- Article
Trends in cervical cancer incidence and mortality of young and middle adults in Japan.
- Published in:
- Cancer Science, 2022, v. 113, n. 5, p. 1801, doi. 10.1111/cas.15320
- By:
- Publication type:
- Article
Development and validation of an RNA sequencing panel for gene fusions in soft tissue sarcoma.
- Published in:
- Cancer Science, 2022, v. 113, n. 5, p. 1843, doi. 10.1111/cas.15317
- By:
- Publication type:
- Article
Novel antiangiogenic therapy targeting biglycan using tumor endothelial cell‐specific liposomal siRNA delivery system.
- Published in:
- Cancer Science, 2022, v. 113, n. 5, p. 1855, doi. 10.1111/cas.15323
- By:
- Publication type:
- Article
Anticancer effect of locally applicable aptamer‐conjugated gemcitabine‐loaded atelocollagen patch in pancreatic cancer patient–derived xenograft models.
- Published in:
- Cancer Science, 2022, v. 113, n. 5, p. 1752, doi. 10.1111/cas.15318
- By:
- Publication type:
- Article
Genomic analysis of familial pancreatic cancers and intraductal papillary mucinous neoplasms: A cross‐sectional study.
- Published in:
- Cancer Science, 2022, v. 113, n. 5, p. 1821, doi. 10.1111/cas.15316
- By:
- Publication type:
- Article
PP6 deficiency in mice with KRAS mutation and Trp53 loss promotes early death by PDAC with cachexia‐like features.
- Published in:
- Cancer Science, 2022, v. 113, n. 5, p. 1613, doi. 10.1111/cas.15315
- By:
- Publication type:
- Article
Component with abundant immune‐related cells in combined hepatocellular cholangiocarcinoma identified by cluster analysis.
- Published in:
- Cancer Science, 2022, v. 113, n. 5, p. 1564, doi. 10.1111/cas.15313
- By:
- Publication type:
- Article
Dahuang Fuzi Baijiang decoction restricts progenitor to terminally exhausted T cell differentiation in colorectal cancer.
- Published in:
- Cancer Science, 2022, v. 113, n. 5, p. 1739, doi. 10.1111/cas.15311
- By:
- Publication type:
- Article
Parsaclisib in Japanese patients with relapsed or refractory B‐cell lymphoma (CITADEL‐111): A phase Ib study.
- Published in:
- Cancer Science, 2022, v. 113, n. 5, p. 1702, doi. 10.1111/cas.15308
- By:
- Publication type:
- Article
Trans‐homophilic interaction of CADM1 promotes organ infiltration of T‐cell lymphoma by adhesion to vascular endothelium.
- Published in:
- Cancer Science, 2022, v. 113, n. 5, p. 1669, doi. 10.1111/cas.15307
- By:
- Publication type:
- Article
Adjuvant Chemotherapy for Endometrial Cancer (ACE) trial: A randomized phase II study for advanced endometrial carcinoma.
- Published in:
- Cancer Science, 2022, v. 113, n. 5, p. 1693, doi. 10.1111/cas.15310
- By:
- Publication type:
- Article
Water‐soluble dietary fiber alleviates cancer‐induced muscle wasting through changes in gut microenvironment in mice.
- Published in:
- Cancer Science, 2022, v. 113, n. 5, p. 1789, doi. 10.1111/cas.15306
- By:
- Publication type:
- Article
Serial circulating tumor DNA monitoring of CDK4/6 inhibitors response in metastatic breast cancer.
- Published in:
- Cancer Science, 2022, v. 113, n. 5, p. 1808, doi. 10.1111/cas.15304
- By:
- Publication type:
- Article
The link between menin and pleiotrophin in the tumor biology of pancreatic neuroendocrine neoplasms.
- Published in:
- Cancer Science, 2022, v. 113, n. 5, p. 1575, doi. 10.1111/cas.15301
- By:
- Publication type:
- Article
DCAF13 promotes breast cancer cell proliferation by ubiquitin inhibiting PERP expression.
- Published in:
- Cancer Science, 2022, v. 113, n. 5, p. 1587, doi. 10.1111/cas.15300
- By:
- Publication type:
- Article
An oral first‐in‐class small molecule RSK inhibitor suppresses AR variants and tumor growth in prostate cancer.
- Published in:
- Cancer Science, 2022, v. 113, n. 5, p. 1731, doi. 10.1111/cas.15280
- By:
- Publication type:
- Article
Tissue factor and its procoagulant activity on cancer‐associated thromboembolism in pancreatic cancer: Comment by Mackman et al.
- Published in:
- Cancer Science, 2022, v. 113, n. 5, p. 1885, doi. 10.1111/cas.15276
- By:
- Publication type:
- Article
In this issue: Volume 113, Issue 5, May 2022.
- Published in:
- Cancer Science, 2022, v. 113, n. 5, p. 1553, doi. 10.1111/cas.14952
- Publication type:
- Article
Issue Information.
- Published in:
- Cancer Science, 2022, v. 113, n. 5, p. 1549, doi. 10.1111/cas.14951
- Publication type:
- Article